ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,846.43
      1.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      09/26/20117:00AMPR Newswire (US)Aeterna Zentaris Announces Interim Data for its Phase 1/2 Trial with AEZS-108 in Prostate Cancer at ESMO Congress - AEZS-108 ...NASDAQ:AEZSAeterna Zentaris Inc
      09/21/20117:30AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming 6th Annual JMP Securities Healthcare Conference in New YorkNASDAQ:AEZSAeterna Zentaris Inc
      09/19/20119:00AMMarketwiredGlobal Situation & Resulting Influences - Research Report on Keryx Biopharmaceuticals and AEterna Zentaris Inc. (USA)NASDAQ:AEZSAeterna Zentaris Inc
      09/19/20118:16AMMarketwiredHeightened FDA Scrutiny Threatens Zalicus and AEterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
      09/14/20116:30AMPR Newswire (US)Aeterna Zentaris Presents Positive Final Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ESGO...NASDAQ:AEZSAeterna Zentaris Inc
      09/06/20118:16AMMarketwiredAEterna Zentaris and AVI BioPharma Maintain Steady PipelinesNASDAQ:AEZSAeterna Zentaris Inc
      09/01/20117:30AMPR Newswire (US)Aeterna Zentaris to Present at Two Upcoming Investment Conferences in the United StatesNASDAQ:AEZSAeterna Zentaris Inc
      08/31/20118:35AMPR Newswire (US)Aeterna Zentaris Announces Completion of Interim Analysis by Data Safety Monitoring Board for the Phase 3 Study of Perifosine...NASDAQ:AEZSAeterna Zentaris Inc
      08/31/20116:50AMGlobeNewswire Inc.Biotech Buzz; Aeterna Zentaris is Today's Focus Stock on MicroStockProfit.comNASDAQ:AEZSAeterna Zentaris Inc
      08/30/20118:30AMPR Newswire (US)Aeterna Zentaris Announces Favorable Top-Line Results of Completed Phase 3 Study on AEZS-130 as First Oral Diagnostic Test fo...NASDAQ:AEZSAeterna Zentaris Inc
      08/30/20117:30AMPR Newswire (US)Aeterna Zentaris Announces Results of its Novel Orally Active Anticancer Erk Inhibitor at the American Chemical Society Natio...NASDAQ:AEZSAeterna Zentaris Inc
      08/23/20117:30AMPR Newswire (US)Aeterna Zentaris to Present Poster on Novel Oral Anticancer Erk Inhibitors at Upcoming American Chemical Society's National M...NASDAQ:AEZSAeterna Zentaris Inc
      08/12/20118:16AMMarketwiredBig Pharma to Shift Focus to Biotech Firms Such as AEterna Zentaris and ADVENTRXNASDAQ:AEZSAeterna Zentaris Inc
      08/11/201111:56AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      08/11/201111:55AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      08/10/20113:00PMPR Newswire (US)Aeterna Zentaris Reports Second Quarter 2011 Financial and Operating ResultsNASDAQ:AEZSAeterna Zentaris Inc
      08/03/20117:30AMPR Newswire (US)Aeterna Zentaris to Announce Second Quarter 2011 Financial and Operating Results on August 10, 2011NASDAQ:AEZSAeterna Zentaris Inc
      08/02/20117:30AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming Canaccord Genuity 30th Annual Growth Conference in BostonNASDAQ:AEZSAeterna Zentaris Inc
      07/27/20118:35AMPR Newswire (US)Aeterna Zentaris Announces Completion of Patient Recruitment for Phase 3 Trial with Perifosine in Refractory Advanced Colorec...NASDAQ:AEZSAeterna Zentaris Inc
      07/26/20111:28PMPR Newswire (US)Aeterna Zentaris Completes Phase 3 Study on AEZS-130 as First Oral Diagnostic Test for Adult Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
      07/22/20118:16AMMarketwiredPromising Products From AEterna Zentaris and Celsion Eager to Defy OddsNASDAQ:AEZSAeterna Zentaris Inc
      07/20/20117:30AMPR Newswire (US)Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Can...NASDAQ:AEZSAeterna Zentaris Inc
      07/18/20117:30AMPR Newswire (US)Aeterna Zentaris Announces Poster Presentation on Final Phase 2 Results for AEZS-108 in Endometrial Cancer at Upcoming European NASDAQ:AEZSAeterna Zentaris Inc
      07/12/20117:30AMPR Newswire (US)Aeterna Zentaris Granted Patent for Perifosine by European Patent OfficeNASDAQ:AEZSAeterna Zentaris Inc
      07/07/20117:30AMPR Newswire (US)Aeterna Zentaris Announces Poster Presentation of Phase 1/2 Results for AEZS-108 in Prostate Cancer at Upcoming European SocietyNASDAQ:AEZSAeterna Zentaris Inc
      06/30/20116:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      06/30/20116:01AMEdgar (US Regulatory)Voluntary supplemental material filed pursuant to Section 11(a) of the Securities Act of 1933 by foreign issuers (SUPPL)NASDAQ:AEZSAeterna Zentaris Inc
      06/29/20114:15PMPR Newswire (US)Aeterna Zentaris Announces "At-the-Market" Issuance ProgramNASDAQ:AEZSAeterna Zentaris Inc
      06/23/20117:00AMPR Newswire (US)U.S. Life Science Companies Raise $53 Million through Activity of 19 At-the-Market (ATM) Offerings in First Quarter of 2011, DatNASDAQ:AEZSAeterna Zentaris Inc
      06/09/20118:16AMMarketwiredVical and AEterna Zentaris -- Shining Stars in a Booming SectorNASDAQ:AEZSAeterna Zentaris Inc
       Showing the most relevant articles for your search:NASDAQ:AEZS